Analysis Life Sciences Thank You The 51 regulations that FDA is currently working on
Agency IQ
JUNE 16, 2023
to provide notice and an opportunity for owners or consignees of the drug to appear before the Agency and introduce testimony prior to the destruction of their drug. The rule, will also, if finalized, address communication with State boards of pharmacy. The final rule will amend the administrative destruction provisions in 21 CFR 1.94
40 
Let's personalize your content